Cardiac allograft vasculopathy medical therapy

Cardiac allograft vasculopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Cardiac allograft vasculopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Coronary Angiography
Intravascular Ultrasound
Optical Coherence Tomography
CT
MRI
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cardiac allograft vasculopathy medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cardiac allograft vasculopathy medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cardiac allograft vasculopathy medical therapy
CDC on Cardiac allograft vasculopathy medical therapy
Cardiac allograft vasculopathy medical therapy in the news
Blogs on Cardiac allograft vasculopathy medical therapy
Directions to Hospitals Treating Cardiac allograft vasculopathy
Risk calculators and risk factors for Cardiac allograft vasculopathy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Medical Therapy

Nonpharmacologic Interventions

• Retransplantation
• [[Percutaneous coronary interventions
• Coronary artery bypass grafting
• Transmyocardial laser revascularization
• Heparin induced/mediated extracorporeal LDL plasmapheresis (HELP)